NA
Device Pacemakers
PDI 00763000162443
General payments
$4,160
Research payments
$853,466
Through program year 2025, $4,160 in general payments and $853,466 in research payments were reported against NA (Pacemakers).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,039 | 43 |
| 2024 | General | $695 | 41 |
| 2024 | Research | $82,933 | 19 |
| 2023 | General | $445 | 27 |
| 2023 | Research | $280,909 | 61 |
| 2022 | General | $1,980 | 71 |
| 2022 | Research | $489,625 | 50 |
Breakdown
The top 5 of 43 recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
182 general · 130 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.